POLINSKY DAVID enters ERNEXA THERAPEUTICS INC. with 8K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/27/2026ACC: 0001493152-26-040466
8K
Baseline shares
0.00
Direct ownership
0 positions
8K
Derivative underlying
1 instrument
1
Security positions
8K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned8K
Total
8K indirect8K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8K | Indirect |
| Total | 8K | 8K indirect |
Derivative Holdings1
Warrant
IndirectUnderlying security
Common Stock
Underlying shares
8K
Shares owned
N/A
Exercise price
17.00
Expiration
—
Exercise window
—
Total
Underlying
8K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant Indirect | Common Stock | 17.00 | — | — | 8K | N/A |
| Total | 8K | 0.00 | ||||